Cargando…

Antiseptic drugs and disinfectants with special scrutiny of COVID-19 pandemic related side effects

This review covers publications during the period of January 2020 to December 2020 on adverse reactions to antiseptic drugs and disinfectants. Specific agents discussed are alcohols (ethanol, isopropanol), aldehydes (formaldehyde), guanidines (chlorhexidine, polyhexamethylene guanidine, and polyhexa...

Descripción completa

Detalles Bibliográficos
Autor principal: Lachenmeier, Dirk W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488688/
http://dx.doi.org/10.1016/bs.seda.2021.03.001
_version_ 1784578214829490176
author Lachenmeier, Dirk W.
author_facet Lachenmeier, Dirk W.
author_sort Lachenmeier, Dirk W.
collection PubMed
description This review covers publications during the period of January 2020 to December 2020 on adverse reactions to antiseptic drugs and disinfectants. Specific agents discussed are alcohols (ethanol, isopropanol), aldehydes (formaldehyde), guanidines (chlorhexidine, polyhexamethylene guanidine, and polyhexamethylene biguanidine), benzalkonium compounds, triclocarban, povidone-iodine, and sodium hypochlorite. No new data were identified for glutaraldehyde, cetrimide, ethylene oxide, tosylchloramide, triclosan, iodine, and phenolic compounds. The use of antiseptic drugs and disinfectants has been considerably increased during 2020 in a variety of medical and occupational settings, in commerce and gastronomy, as well as in the household, due to their antiviral properties against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the Coronavirus Disease 2019 (COVID-19) pandemic. Exposure was additionally increased by widespread misinformation on social media for non-evidence based disinfectant use, even including ingestion or injection, as well as by questionable practices such as environmental spraying or disinfectant gates. Irritant effects on the respiratory system, skin and eyes were the most common adverse reaction, while the widespread and sometimes excessive use led to increased reports of poisonings, as well as cases of disinfectant adulteration including dilution into ineffective concentrations or addition of toxic agents such as methanol.
format Online
Article
Text
id pubmed-8488688
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84886882021-10-04 Antiseptic drugs and disinfectants with special scrutiny of COVID-19 pandemic related side effects Lachenmeier, Dirk W. Side Effects of Drugs Annual Article This review covers publications during the period of January 2020 to December 2020 on adverse reactions to antiseptic drugs and disinfectants. Specific agents discussed are alcohols (ethanol, isopropanol), aldehydes (formaldehyde), guanidines (chlorhexidine, polyhexamethylene guanidine, and polyhexamethylene biguanidine), benzalkonium compounds, triclocarban, povidone-iodine, and sodium hypochlorite. No new data were identified for glutaraldehyde, cetrimide, ethylene oxide, tosylchloramide, triclosan, iodine, and phenolic compounds. The use of antiseptic drugs and disinfectants has been considerably increased during 2020 in a variety of medical and occupational settings, in commerce and gastronomy, as well as in the household, due to their antiviral properties against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the Coronavirus Disease 2019 (COVID-19) pandemic. Exposure was additionally increased by widespread misinformation on social media for non-evidence based disinfectant use, even including ingestion or injection, as well as by questionable practices such as environmental spraying or disinfectant gates. Irritant effects on the respiratory system, skin and eyes were the most common adverse reaction, while the widespread and sometimes excessive use led to increased reports of poisonings, as well as cases of disinfectant adulteration including dilution into ineffective concentrations or addition of toxic agents such as methanol. Elsevier B.V. 2021 2021-10-04 /pmc/articles/PMC8488688/ http://dx.doi.org/10.1016/bs.seda.2021.03.001 Text en Copyright © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lachenmeier, Dirk W.
Antiseptic drugs and disinfectants with special scrutiny of COVID-19 pandemic related side effects
title Antiseptic drugs and disinfectants with special scrutiny of COVID-19 pandemic related side effects
title_full Antiseptic drugs and disinfectants with special scrutiny of COVID-19 pandemic related side effects
title_fullStr Antiseptic drugs and disinfectants with special scrutiny of COVID-19 pandemic related side effects
title_full_unstemmed Antiseptic drugs and disinfectants with special scrutiny of COVID-19 pandemic related side effects
title_short Antiseptic drugs and disinfectants with special scrutiny of COVID-19 pandemic related side effects
title_sort antiseptic drugs and disinfectants with special scrutiny of covid-19 pandemic related side effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488688/
http://dx.doi.org/10.1016/bs.seda.2021.03.001
work_keys_str_mv AT lachenmeierdirkw antisepticdrugsanddisinfectantswithspecialscrutinyofcovid19pandemicrelatedsideeffects